Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.

Roddy J, Clark I, Hazleman BL, Compston DA, Scolding NJ.

J Neurol. 1994 Aug;241(9):557-60.

PMID:
7528270
[PubMed - indexed for MEDLINE]
2.

Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system.

Zajicek J, Wing M, Skepper J, Compston A.

Lab Invest. 1995 Jul;73(1):128-38.

PMID:
7541492
[PubMed - indexed for MEDLINE]
3.

Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.

Piddlesden SJ, Morgan BP.

J Neuroimmunol. 1993 Nov-Dec;48(2):169-75.

PMID:
7693753
[PubMed - indexed for MEDLINE]
4.

The expression of complement regulatory proteins by adult human oligodendrocytes.

Scolding NJ, Morgan BP, Compston DA.

J Neuroimmunol. 1998 Apr 1;84(1):69-75.

PMID:
9600710
[PubMed - indexed for MEDLINE]
5.

Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.

Väkevä A, Laurila P, Meri S.

Lab Invest. 1992 Nov;67(5):608-16.

PMID:
1279272
[PubMed - indexed for MEDLINE]
6.

Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis.

Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L, Seya T, McFarland HF, Jacobson S.

Ann Neurol. 2001 Oct;50(4):486-93.

PMID:
11603380
[PubMed - indexed for MEDLINE]
7.

Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.

Traugott U, Raine CS.

Neurology. 1981 Jun;31(6):695-700.

PMID:
7017459
[PubMed - indexed for MEDLINE]
8.

Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.

Scolding NJ, Morgan BP, Houston WA, Linington C, Campbell AK, Compston DA.

Nature. 1989 Jun 22;339(6226):620-2.

PMID:
2733792
[PubMed - indexed for MEDLINE]
9.

The expression of CD59 in normal human nervous tissue.

Vedeler C, Ulvestad E, Bjørge L, Conti G, Williams K, Mørk S, Matre R.

Immunology. 1994 Aug;82(4):542-7.

PMID:
7530684
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis.

Lehto T, Honkanen E, Teppo AM, Meri S.

Kidney Int. 1995 May;47(5):1403-11.

PMID:
7543624
[PubMed - indexed for MEDLINE]
11.

Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).

Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP.

Am J Pathol. 1996 Jul;149(1):129-42.

PMID:
8686736
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antibodies to simian virus 5 in patients with multiple sclerosis and other neurological disorders.

Brankin B, Wisdom GB, Allen IV, Hawkins SA, Cosby SL.

J Neurol Sci. 1989 Feb;89(2-3):181-7.

PMID:
2538574
[PubMed - indexed for MEDLINE]
13.

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.

Padberg F, Feneberg W, Schmidt S, Schwarz MJ, Körschenhausen D, Greenberg BD, Nolde T, Müller N, Trapmann H, König N, Möller HJ, Hampel H.

J Neuroimmunol. 1999 Oct 29;99(2):218-23.

PMID:
10505978
[PubMed - indexed for MEDLINE]
14.

Presence of autoantibodies against complement regulatory proteins in relapsing-remitting multiple sclerosis.

Pintér C, Beltrami S, Caputo D, Ferrante P, Clivio A.

J Neurovirol. 2000 May;6 Suppl 2:S42-6.

PMID:
10871784
[PubMed - indexed for MEDLINE]
15.

Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules.

Hakulinen J, Meri S.

Immunology. 1995 Jul;85(3):495-501.

PMID:
7558140
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland.

Bardenstein DS, Dietz Y, Lass JH, Medof ME.

Curr Eye Res. 1994 Dec;13(12):851-5.

PMID:
7536649
[PubMed - indexed for MEDLINE]
17.

Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.

Mäenpää A, Junnikkala S, Hakulinen J, Timonen T, Meri S.

Am J Pathol. 1996 Apr;148(4):1139-52.

PMID:
8644856
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.

Marchbank KJ, Morgan BP, van den Berg CW.

Immunology. 1995 May;85(1):146-52.

PMID:
7543447
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis.

Sellebjerg F, Jensen J, Ryder LP.

J Neuroimmunol. 1998 Apr 15;84(2):179-87.

PMID:
9628461
[PubMed - indexed for MEDLINE]
20.

Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.

McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL.

Transplantation. 1995 Apr 27;59(8):1177-82.

PMID:
7537395
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk